| CPC A61F 9/0017 (2013.01) [A61K 9/0051 (2013.01); A61F 2210/0014 (2013.01); A61F 2210/0061 (2013.01); A61F 2250/001 (2013.01); A61F 2250/0068 (2013.01); A61F 2250/0069 (2013.01)] | 25 Claims |

|
1. A drug delivery device configured to be at least partially implanted in an eye, the device comprising:
a retention structure positioned near a proximal end region of the device;
a porous drug release element positioned in fluid communication with an outlet of the device;
an elongated core element having a longitudinal axis extending from a proximal end of the elongated core element to a distal end of the elongated core element; and
a reservoir wall positioned around and eccentric to the longitudinal axis of the elongated core element, the reservoir wall defining a reservoir volume configured to contain one or more therapeutic agents, the reservoir volume in fluid communication with the outlet through the porous drug release element,
wherein the reservoir wall is configured to transition from an insertion configuration having a first three-dimensional shape to a deployed configuration having a second three-dimensional shape such that the second three-dimensional shape is eccentrically positioned relative to the longitudinal axis of the elongated core element.
|